Verified email-pattern data for Foresee Pharmaceuticals is currently limited. You can still use the company insights and contact sections below.
Foresee Pharmaceuticals is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (TPEx: 6576). Foresee's R&D efforts are focused on two key areas, namely its unique Stabilized Injectable Formulation (SIF) long-acting injectable technology with derived drug products targeting specialty markets and secondly, its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs.
Foresee's product portfolio includes late and early-stage programs.
CAMCEVI 6-month formulation, for the treatment of advanced prostate cancer, is now approved in the U.S., Canada, EU, Taiwan and Israel and launched in the U.S.. Additionally, the U.S. NDA for the 3-month version of CAMCEVI has been submitted. For the second indication of CAMCEVI 42 mg, central precocious puberty (CPP), the Casppian phase 3 clinical study, has been initiated.
FP-025, a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, has been investigated in a Phase 2 POC study in allergic asthmatic patients. The study has been completed with positive outcomes, with future development in rare immune-fibrotic diseases. FP-020, a follow-on oral MMP-12 inhibitor, for which a Phase 1 study has been completed, with development targeted in severe asthma, COPD and IBD.
FP-045 is a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which the FuschiA Phase 1b/2 Fanconi Anemia study is currently being initiated, and the Phase 2 WINDWARD study in pulmonary hypertension-interstitial lung disease (PH-ILD) patients is in planning with targeted initiation in the fourth quarter of 2024. Building on the compelling biology of ALDH2, and translational data from several Foresee ALDH2 activators, a follow-on candidate from a new series of compounds is being selected for development in metabolic syndrome/healthy weight loss and the broader cardiovascular-renal-metabolic space.
Company Details
- Employees
- 47
- Founded
- -
- Address
- No.19-3, Sanchong Rd., Nangang Dist., Taipei City, Taiwan, 9f-2,united States
- Industry
- Biotechnology Research
- Website
- http://www.foreseepharma.com/
- Keywords
- Pharmaceuticals, Rare Disease, Oncology, Neuroscience, Urology, Pulmonary/Respiratory Diseases, Cardiology/Vascular Diseases, Biotechnology.
- HQ
- Taipei
Foresee Pharmaceuticals Questions
Foresee Pharmaceuticals's website is http://www.foreseepharma.com/
Foresee Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/foreseepharma
Foresee Pharmaceuticals has
47 employees.
View email and phone details for 47
employees at Foresee Pharmaceuticals.
Foresee Pharmaceuticals's industry is
Biotechnology Research
Foresee Pharmaceuticals's top competitors are
Tlc Biosciences,
Obi Pharma,
Eli Lilly And Company,
Qps Holdings, Llc,
Amneal Pharmaceuticals,
Dialectic Therapeutics Inc,
Bioboston Consulting,
Eilean Therapeutics,
Lumosa Therapeutics Co., Ltd.,
Daiichi Sankyo Us.
Foresee Pharmaceuticals's categories are Biotechnology Research
Foresee Pharmaceuticals's founding year is 2013
Explore related pages
Related company profiles:
Top Foresee Pharmaceuticals Employees
-
Scott Johnson
Senior Director And Head Of Quality…
New York City Metropolitan Area, United States, United States5pahc.com, lupin.com, wcrx.com, oysterpointrx.com, pharnext.com -
Bassem Elmankabadi, M.D.
Senior Vice President, Clinical…
San Francisco, California, United States, United States3blademed.com, fibrogen.com, msn.com -
Bill Miller
Vice President Regulatory Affairs At…
Exton, Pennsylvania, United States, United States5swiftwater.com, cslbehring.com, pharmalex.com, yes-group.com, foreseepharma.com -
Chen Chang Lee
Senior Researcher
Taipei City, Taipei City, Taiwan, Taiwan, Province Of China1email.uc.edu
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.